---
$id: https://graph.org.ai/products/commodity/51112005
$type: Product
source: UNSPSC
code: "51112005"
title: "Imatinib"
class: "51112000"
classTitle: "Tyrosine kinase inhibitors"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Imatinib

**UNSPSC Code**: 51112005
**Class**: [Tyrosine kinase inhibitors](Tyrosine kinase inhibitors.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a tyrosine kinase inhibitor with the molecular formula C29H31N7O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BKJ8M8G5HI, chemically known as benzamide, 4-((4-methyl)-1-piperazinyl)methyl)-n-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)- but generally known as imatinib, which bears US NIH Compound Identifier 5291. European Medicines Agency schedules Imatinib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25387. The term IMATINIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 3-4, 2001, List 46). World Health Organization schedules imatinib in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule imatinib under HS 29335995 and SITC 51576. As of Q4 2014, IMATINIB remains the US FDA Preferred Term for this commodity. Imatinib bears US NLM identifiers UMLS ID C0935989 and NCI Concept Code C62035. SMILES: O=C(NC1CC(NC2NC(C3CCCNC3)CCN2)C(CC1)C)C1CCC(CN2CCN(CC2)C)CC1.

